Perfusion computed tomographic assessment of early hepatocellular carcinoma in cirrhotic liver disease: initial observations
- PMID: 19204443
- DOI: 10.1097/RCT.0b013e318161dc58
Perfusion computed tomographic assessment of early hepatocellular carcinoma in cirrhotic liver disease: initial observations
Abstract
Objective: To prospectively assess perfusion computed tomography (CT) for evaluation of tumor vascularity of early hepatocellular carcinoma (HCC) in patients with cirrhosis.
Methods: The study cohort included 30 patients who had Child-Pugh class A or B liver cirrhosis and a single histopathologically confirmed HCC not exceeding 3 cm in diameter. All patients underwent perfusion CT study using a multidetector 16-slice CT. Four perfusion parameters were measured for the HCCs and cirrhotic liver parenchyma: hepatic perfusion (HP), blood volume (BV), arterial perfusion (AP), and time to peak (TTP). Perfusion parameters were described with quartile (qt) values of their distribution; univariate paired Wilcoxon signed rank test was used for statistical analysis.
Results: The values of perfusion parameters measured within tumor tissue were the following: HP (milliliters per 100 g per minute): median = 45.7 (first qt = 35.3; third qt = 61.3); BV (milliliters per 100 mg): median = 20.6 (first qt = 13.0; third qt = 27.6); AP (milliliters per minute): median = 44.2 (first qt = 36.7; third qt = 57.0); TTP (seconds): median = 18.7 (first q = 15.9; third qt = 24.0). Our data showed that HP, BV, and AP values were higher (P < 0.001), whereas TTP was lower (P < 0.001), in HCCs relative to the cirrhotic liver parenchyma. For all the CT perfusion parameters calculated, there was a significant difference between HCC and background cirrhotic liver.
Conclusions: Preliminary results suggest that in patients with cirrhosis and early HCC, perfusion CT is a feasible technique for noninvasive assessment of tumor vascularity.
Similar articles
-
Hepatocellular carcinoma in cirrhotic liver disease: functional computed tomography with perfusion imaging in the assessment of tumor vascularization.Acad Radiol. 2008 Jul;15(7):919-27. doi: 10.1016/j.acra.2008.02.005. Acad Radiol. 2008. PMID: 18572129
-
Perfusion CT in cirrhotic patients with early stage hepatocellular carcinoma: assessment of tumor-related vascularization.Eur J Radiol. 2010 Jan;73(1):148-52. doi: 10.1016/j.ejrad.2008.10.014. Epub 2008 Dec 2. Eur J Radiol. 2010. PMID: 19054640
-
Hepatocellular carcinoma treated with transarterial chemoembolization: dynamic perfusion-CT in the assessment of residual tumor.World J Gastroenterol. 2010 Dec 21;16(47):5993-6000. doi: 10.3748/wjg.v16.i47.5993. World J Gastroenterol. 2010. PMID: 21157976 Free PMC article.
-
Imaging of early hepatocellular carcinoma and adenomatous hyperplasia (dysplastic nodules) with dynamic ct and a combination of CT and angiography: experience with resected liver specimens.Intervirology. 2004;47(3-5):199-208. doi: 10.1159/000078473. Intervirology. 2004. PMID: 15383730 Review.
-
Hepatocellular carcinoma in advanced liver cirrhosis: CT detection in transplant patients.Abdom Imaging. 2004 Mar-Apr;29(2):203-7. doi: 10.1007/s00261-003-0114-y. Abdom Imaging. 2004. PMID: 15290946 Review.
Cited by
-
DCE-MRI in hepatocellular carcinoma-clinical and therapeutic image biomarker.World J Gastroenterol. 2014 Mar 28;20(12):3125-34. doi: 10.3748/wjg.v20.i12.3125. World J Gastroenterol. 2014. PMID: 24695624 Free PMC article. Review.
-
Hepatocellular carcinoma: perfusion quantification with dynamic contrast-enhanced MRI.AJR Am J Roentgenol. 2013 Oct;201(4):795-800. doi: 10.2214/AJR.12.9798. AJR Am J Roentgenol. 2013. PMID: 24059368 Free PMC article.
-
Response Assessment of Primary Liver Tumors to Novel Therapies: an Imaging Perspective.J Gastrointest Surg. 2023 Oct;27(10):2245-2259. doi: 10.1007/s11605-023-05762-1. Epub 2023 Jul 18. J Gastrointest Surg. 2023. PMID: 37464140 Review.
-
Iodine concentration as a perfusion surrogate marker in oncology: Further elucidation of the underlying mechanisms using Volume Perfusion CT with 80 kVp.Eur Radiol. 2016 Sep;26(9):2929-36. doi: 10.1007/s00330-015-4154-9. Epub 2015 Dec 17. Eur Radiol. 2016. PMID: 26679179
-
Role of Computed Tomography Perfusion in Patients with Liver Cirrhosis and Hepatocellular Carcinoma.J Clin Exp Hepatol. 2024 Jan-Feb;14(1):101259. doi: 10.1016/j.jceh.2023.07.412. Epub 2023 Jul 26. J Clin Exp Hepatol. 2024. PMID: 38076381 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous